Development and Validation of The Post-RT LARS Prediction Model (PORTLARS)
PORTLARS
1 other identifier
observational
901
1 country
1
Brief Summary
Bowel dysfunction is common after a restorative rectal cancer resection. Neoadjuvant radiotherapy is an influential factor that impairs bowel function and quality of life. However, almost half patients who have received primary surgery with preoperative radiotherapy are able to restore a good or moderate bowel function in the long term. This multicenter observational study aims to identify the risk factors of severe bowel dysfunction after rectal cancer resection and neoadjuvant radiotherapy, in accordance with the LARS score, and to build a model that predicts long-term major LARS in the early stage of follow-up. Development and validation cohorts are enrolled from tertiary hospitals in China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 6, 2020
CompletedFirst Submitted
Initial submission to the registry
November 15, 2021
CompletedFirst Posted
Study publicly available on registry
November 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2022
CompletedNovember 30, 2022
November 1, 2022
2.7 years
November 15, 2021
November 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Area under the curve (AUC)
The AUC of PORTLARS in predicting major bowel dysfunction after restorative rectal cancer resection with neoadjuvant radiotherapy. The AUC is evaluated by calculating the area under curve of receiver operating characteristics which plots the proportion of true positive cases (sensitivity) against the proportion of false positive cases (1-specificity) based on various predictive probability threshold.
Over one year after restorative rectal cancer resection
Secondary Outcomes (4)
Sensitivity
Over one year after restorative rectal cancer resection
Specificity
Over one year after restorative rectal cancer resection
Positive prediction value (PPV)
Over one year after restorative rectal cancer resection
Negative prediction value (NPV)
Over one year after restorative rectal cancer resection
Other Outcomes (1)
Net reclassification index (NRI)
Over one year after restorative rectal cancer resection
Study Arms (3)
Development
A primary cohort of eligible patients from the Sixth Affiliated Hospital of Sun Yat-sen University is used for model derivation.
Internal cross-validation
A cohort of consecutive patients from the Sixth Affiliated Hospital of Sun Yat-sen University is used for internal cross-validation.
External validation
An independent cohort of eligible patients from other hospitals is used for external validation.
Interventions
The LARS score is used for assessment of bowel dysfunction after rectal cancer resection.
Eligibility Criteria
Patients who underwent preoperative radiotherapy and curative low anterior resection for nonmetastatic rectal cancer.
You may qualify if:
- Curative low anterior resection for nonmetastatic rectal cancer
- Preoperative radiotherapy
You may not qualify if:
- Death
- Metastasis or recurrence
- Postoperative radiotherapy
- Cognitive disorder
- Intestinal stoma
- Rectal cancer resection for \<12 months
- Stoma reversal for \<6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sixth Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510000, China
Related Publications (1)
Qin Q, Huang B, Wu A, Gao J, Liu X, Cao W, Ma T, Kuang Y, Guo J, Wu Q, Shao B, Guan Q, Yao H, Zhang X, Wang H; Chinese Radiation Intestinal Injury Research Group. Development and Validation of a Post-Radiotherapy Prediction Model for Bowel Dysfunction After Rectal Cancer Resection. Gastroenterology. 2023 Dec;165(6):1430-1442.e14. doi: 10.1053/j.gastro.2023.08.022. Epub 2023 Aug 23.
PMID: 37625498DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Qiyuan Qin, M.D.
Sixth Affiliated Hospital, Sun Yat-sen University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 15, 2021
First Posted
November 22, 2021
Study Start
March 6, 2020
Primary Completion
October 31, 2022
Study Completion
October 31, 2022
Last Updated
November 30, 2022
Record last verified: 2022-11